Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 3;2(4):608-614.
doi: 10.1016/j.adro.2017.07.004. eCollection 2017 Oct-Dec.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

R Charles Nichols  1 , Chen Hu  2   3 , Jean-Paul Bahary  4 , Kenneth L Zeitzer  5 , Luis Souhami  6 , Mark H Leibenhaut  7 , Marvin Rotman  8 , Elizabeth M Gore  9 , Alexander G Balogh  10 , David McGowan  11 , Jeff Michalski  12 , Adam Raben  13 , Shari Rudoler  14 , Christopher U Jones  15 , Howard Sandler  16
Affiliations

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

R Charles Nichols et al. Adv Radiat Oncol. .

Abstract

Objectives: We reviewed testosterone changes for patients who were treated with radiation therapy (RT) alone on NRG oncology RTOG 9408.

Methods and materials: Patients (T1b-T2b, prostate-specific antigen <20 ng/mL) were randomized between RT alone and RT plus 4 months of androgen ablation. Serum testosterone (ST) levels were investigated at enrollment, RT completion, and the first follow-up 3 months after RT. The Wilcoxon signed rank test was used to compare pre- and post-treatment ST levels in patients who were randomized to the RT-alone arm.

Results: Of 2028 patients enrolled, 992 patients were randomized to receive RT alone and 917 (92.4%) had baseline ST values available and completed RT. Of these 917 patients, immediate and 3-month post-RT testosterone levels were available for 447 and 373 patients, respectively. Excluding 2 patients who received hormonal therapy off protocol after RT, 447 and 371 patients, respectively, were analyzed. For all patients, the median change in ST values at completion of RT and at 3-month follow-up were -30.0 ng/dL (p5-p95; -270.0 to 162.0; P < .001) and -34.0 ng/dL (p5-p95, -228.0 to 160.0; P < .01), respectively.

Conclusion: RT for prostate cancer was associated with a median 9.2% decline in ST at completion of RT and a median 9.3% decline 3 months after RT. These changes were statistically significant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Regional lymphatics target volumes. Shown are typical whole pelvis (a) and prostate boost (b) fields used to treat patients enrolled on NRG oncology RTOG 9408. The testicles (in yellow) are shown to be well outside of the radiation therapy beam paths.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Oermann E.K., Suy S., Hanscom H.N. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer. J Hematol Oncol. 2011;4:12. - PMC - PubMed
    1. Pickles T., Graham P., Members of the British Columbia Cancer Agency Prostate Cohort Outcomes Initiative What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol. 2002;167:2448–2452. - PubMed
    1. Daniell H.W., Clark J.C., Pereira S.E. Hypogonadism following prostate-bed radiation therapy for prostate carcinoma. Cancer. 2001;91:1889–1895. - PubMed
    1. Zagars G.K., Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997;39:85–89. - PubMed
    1. Grigsby P.W., Perez C.A. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate. J Urol. 1986;135:726–727. - PubMed